康惠股份2025年预亏超3亿，关联交易及担保事项引关注

Core Viewpoint - Kanghui Co., Ltd. (603139) has disclosed several important announcements, including a projected loss for 2025, plans for related party transactions, and external guarantee matters, while its stock price has increased this year despite a trend of capital outflow [1]. Group 1: Performance and Operating Conditions - The company expects a net profit loss of approximately 327 million yuan for the year 2025, with a loss of about 208 million yuan after excluding non-recurring gains and losses, primarily due to the shutdown of its subsidiary Shaanxi Youbang and the impact of bad debt provisions and asset impairments [2]. Group 2: Related Party Transactions - At the first extraordinary general meeting of 2026, the company approved an estimated total of 54.8 million yuan for related party transactions in 2026, mainly for providing technical services and leasing properties to related parties such as Yian Tianxia and Anhua Data [3]. Group 3: Financial Status - The company has provided a joint liability guarantee of 8 million yuan to its subsidiary Sichuan Chunsheng Pharmaceutical, with a guarantee period of three years from the maturity of the main debt. As of the announcement date, the total amount of external guarantees by the company and its subsidiaries accounts for 10.48% of the most recent audited net assets [4]. Group 4: Stock Performance - As of February 9, 2026, the stock price of Kanghui Co., Ltd. was 23.82 yuan per share, reflecting a year-to-date increase of 16.37%, although there is a trend of net capital outflow from the main funds [5].